Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005431 |
---|---|
Receipt number | R000006444 |
Scientific Title | Multicenter Randomized Controlled Trial of Combination Antiemetic Therapy with Aprepitant/Fosaprepitant in Patients with Colorectal Cancer Receiving Oxaliplatin-based chemotherapy |
Date of disclosure of the study information | 2011/04/14 |
Last modified on | 2019/05/15 16:11:40 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/04/13 10:03:27 | ||
2 | Update | 2011/04/19 13:08:08 | Recruitment status |
|
3 | Update | 2012/10/12 17:02:18 | Public title Public title Acronym Acronym |
|
4 | Update | 2012/10/12 17:06:48 | Narrative objectives1 Narrative objectives1 |
|
5 | Update | 2012/10/12 17:20:41 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
6 | Update | 2013/10/18 11:10:33 | TEL Last name of contact person Last name of contact person Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2014/04/14 14:53:14 | Recruitment status Last follow-up date |
|
8 | Update | 2015/01/09 10:42:37 | UMIN ID1 |
|
9 | Update | 2015/08/12 17:58:48 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results Results Results |
|
10 | Update | 2018/05/14 18:57:52 | Randomization unit |
|
11 | Update | 2018/05/14 18:58:23 | Name of primary person or sponsor Organization |
|
12 | Update | 2018/05/14 19:02:00 | Other related information Other related information |
|
13 | Update | 2019/05/15 09:24:18 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
14 | Update | 2019/05/15 15:52:49 | Recruitment status Date of IRB Anticipated trial start date |
|
15 | Update | 2019/05/15 16:11:40 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |